Aspirin use and cognitive function in the elderly

American Journal of Epidemiology

Volumn 143, Issue 7, 1996, Pages 683-691

  Stürmer, Tii ^a,b,d   Glynn, Robert J ^a,b   Field, Terry S ^a   Taylor, James O ^c   Hennekens, Charles H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c E Boston Neighborhood Health Center   (United States)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

aging; Alzheimer's disease; aspirin; cognition; cohort studies; dementia, multi infarct; incidence

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTHRALGIA; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG INDICATION; ELDERLY CARE; FEMALE; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; TREATMENT OUTCOME;

EID: 0029913163     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008801     Document Type: Article

References (41)

1. Cross PS, Gurland BJ. The epidemiology of dementing disorders. A report on work performed and submitted to the US Congress, Office of Technology assessment. New York, NY: The Columbia University Center for Geriatrics, Gerontology, and Long-Term Care, 1985.
2. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-79.
3. Bachman DL, Wolf PA, Linn R, et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992;42:115-19.
4. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons; higher than previously reported. JAMA 1989;262:2551-6.
5. Davis KL, Thai LJ, Gamzu ER, et al. A double-blind, placebocontrolled multicenter study of tacrine for Alzheimer's disease. N Engl J Med 1992;327:1253-9.
6. Farlow M, Gracon SI, Hershey LA, et al. A controlled trial of tacrine in Alzheimer's disease. JAMA 1992;268:2523-9.
7. Knapp MJ, Knopman DS, Solomon PR, et al. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994;271:985-91.
8. Breteler MM, Claus JJ, van Duijn CM, et al. Epidemiology of Alzheimer's disease. Epidemiol Rev 1992;14:59-82.
9. May FE, Moore MT, Stewart RB, et al. Lack of association of nonsteroidal anti-inflammatory drug use and cognitive decline in the elderly. Gerontology 1992;38:275-9.
10. Breitner JC, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994;44:227-32.
11. Cooper JK. Drug treatment of Alzheimer's disease. Arch Intern Med 1991;151:245-9.
12. Winker MA. Tacrine for Alzheimer's disease. Which patient, what dose? (Editorial). JAMA 1994;271:1023-4.
13. Tomlinson BE, Blessed GL, Roth M. Observations of brains of old people. J Neurol Sci 1970;11:205-42.
14. Skoog I, Nilsson L. Palmertz B, et al. A population-based study of dementia in 85-year-olds. N Engl J Med 1993;328:153-8.
15. Farmer ME, White LR, Abbott RD, et al. Blood pressure and cognitive performance. The Framingham Study. Am J Epidemiol 1987;126:1103-14.
16. Meyer JS, Judd BW, Tawaklna T, et al. Improved cognition after control of risk factors for multi-infarct dementia. JAMA 1986;256:2203-9.
17. Fields WS, Lemak NA, Frankowski RF, et al. Controlled trial of aspirin in cerebral ischemia. II. Surgical group. Stroke 1978;9:309-19.
18. Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978;299:53-9.
19. Swedish Cooperative Study Group. High dose acetylsalicylic acid after cerebral infarction. Stroke 1987;18:325-34.
20. Meyer JS, Rogers RL, McClintic K, et al. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study. J Am Geriatr Soc 1989;37:549-55.
21. Cebul RD. Aspirin and MID. Notes of caution. (Editorial). J Am Geriatr Soc 1989;37:573-5.
22. DeVito CA, Aldridge GW, Wilson A, et al. Framework and development of a comprehensive drug product coding system. Contemp Pharm Prac 1979;2:62-5.
23. Physicians' desk reference. Montvale, NJ: Medical Economics Data Production Company, 1982, 1986, 1993.
24. Kahn RL, Goldfarb AI, Pollack M, et al. Brief objective measures for the determination of mental status in the aged. Am J Psychiatry 1960;117:326-8.
25. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975;23:433-41.
26. Albert M, Smith LA, Scherr PA, et al. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-78.
27. Field TS. Unpublished doctoral dissertation. Boston, MA: Boston University School of Public Health, 1993.
28. Hennekens CH, Willett W, Rosner B, et al. Effects of beer, wine, and liquor in coronary deaths. JAMA 1979;242:1973-4.
29. Rose GA. Cardiovascular survey methods. Second ed. Geneva, Switzerland: World Health Organization, 1982.
30. Kohout FJ, Berkman LF, Evans DA, et al. Two shorter forms of the CES-D depression symptoms index. J Aging Health 1993;5:177-93.
31. Maldonado G, Greenland S. Simulation study of confounderselection strategies. Am J Epidemiol 1993;138:923-36.
32. Zeger SL, Liang K-Y, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049-60.
33. Lipsitz SR, Harrington DP. Analyzing correlated binary data using SAS. Comput Biomed Res 1990;23:268-82.
34. Evans DA, Beckett LA, Albert MS, et al. Level of education and change in cognitive function in a community population of older persons. Ann Epidemiol 1993;3:71-7.
35. Jennrich RI, Schluchter MD. Unbalanced repeated-measures models with structured covariance matrices. Biometrics 1986;42:805-20.
36. Schluchter MD. 5V: Unbalanced repeated measures models with structured covariance matrices. In: Dixon WJ, ed. BMDP statistical software. Vol. 2. Berkeley, CA: University of California, 1990:1207-44.
37. Dubach UC, Rosner B, Stürmer T. An epidemiologic study of abuse of analgesic drugs. Effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987). N Engl J Med 1991;324:155-60.
38. Nelson A, Fogel BS, Faust D. Bedside cognitive screening instruments; a critical assessment. J Nerv Ment Dis 1986;174:73-83.
39. Ritchie K. The screening of cognitive impairment in the elderly: a critical review of current methods. J Clin Epidemiol 1988;41:635-43.
40. Berg L, Miller JP, Storandt M, et al. Mild senile dementia of the Alzheimer type. 2. Longitudinal assessment. Ann Neurol 1988;23:477-84.
41. Hennekens CH, Buring JE. Epidemiology in medicine. Boston, MA: Little, Brown and Co., 1987.